Effects of longJterm lisinopril therapy on central and peripheral hemodynamics in patients with dilated cardiomyopathy

Effects of longJterm lisinopril therapy on central and peripheral hemodynamics in patients with dilated cardiomyopathy

The study was aimed at investigating the effects of a second?generation ACE inhibitor, lisinopril (Diroton), on central and peripheral hemodynamics in patients with dilated cardiomyopathy (DCMP). In total, 39 persons with DCMP and chronic heart failure (CHF), aged 35–55 years, were examined. Diroton...

Full description

Saved in:

Bibliographic Details
Main Authors:	Z. T. Astakhova, T. M. Gatagonova, L. M. Mosin, O. T. Kotsoeva, A. S. Plieva, L. V. Osipova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2008-02-01
Series:	Российский кардиологический журнал
Subjects:	dilated cardiomyopathy chronic heart failure longjterm treatment diroton central and peripheral hemodynamics rheography
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1451
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

Dilated cardiomyopathy: reconceptualization of the problem
by: T. G. Vaykhanskaya, et al.
Published: (2019-05-01)

Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy
by: A. M. Kiselev, et al.
Published: (2019-11-01)

Aortopathy associated with bicuspid aortic valve: advances in clinical and hemodynamics research
by: Minghui Yang, et al.
Published: (2025-05-01)

Similar burden of rare genetic variants in ischemic and non-ischemic dilated cardiomyopathy
by: Louie Cao, et al.
Published: (2025-04-01)

Biventricular Thrombi in a Patient With Dilated Cardiomyopathy
by: Saba Mohammadzadeh, et al.
Published: (2025-08-01)

Thyroid status and levothyroxine natrium effectiveness in patients with dilated cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (2010-06-01)

CLINICAL AND INSTRUMENTAL DATA AND SURVIVAL IN DILATED CARDIOMYOPATHY: THREE-YEAR OBSERVATION RESULTS
by: L. A. Zotova
Published: (2014-07-01)

Association of SCN5A gene polymorphism with dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2021-09-01)

Noncompact Myocardium with Dilated Phenotype: Manifestations, Treatment and Outcomes in Comparison with Other Forms of Dilated Cardiomyopathy Syndrome
by: O. V. Blagova, et al.
Published: (2022-03-01)

Angiography-derived index of microcirculatory resistance as risk stratification tool in dilated cardiomyopathy
by: Ioannis Skalidis, et al.
Published: (2025-09-01)

Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences
by: T. G. Vaykhanskaya, et al.
Published: (2022-11-01)

Heart transplantation in secondary dilated cardiomyopathy due to myocarditis. Case report
by: D. V. Romashova, et al.
Published: (2023-06-01)

Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry
by: Antonella Meloni, et al.
Published: (2025-03-01)

Genetic risk factors for dilated cardiomyopathy
by: T. G. Vaikhanskaya, et al.
Published: (2021-11-01)

RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE
by: T. G. Kulikova, et al.
Published: (2015-09-01)

Lung Function Parameters in Patients with Dilated Cardiomyopathy Complicated by Pulmonary Hypertension
by: T. A. Abdullaev, et al.
Published: (2016-11-01)

Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics
by: Kristian Galanti, et al.
Published: (2025-08-01)

Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy
by: Fan J, et al.
Published: (2025-07-01)

Atrial fibrillation in patients with dilated cardiomyopathy: prevalence, risk factors and prognostic significance
by: T. G. Vaikhanskaya, et al.
Published: (2023-11-01)

Relationship of matrix metalloproteinase-3 -11715A/6A polymorphism (rs35068180) and dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2020-11-01)

Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
by: Michael Gramlich, et al.
Published: (2015-03-01)

A case of Hirschsprung’s disease with segmental dilatation of the colon
by: Hideyuki Yokokawa, et al.
Published: (2023-02-01)

METABOLISM OF FATTY ACIDS IN LEFT VENTRICLE MYOCARDIUM AND THE EFFICACY PROGNOSIS OF CARDIO-RESYNCHRONIZING THERAPY IN DILATED CARDIOMYOPATHY PATIENTS
by: M. O. Gulya, et al.
Published: (2014-09-01)

LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE
by: O. V. Uskova, et al.
Published: (2016-01-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics)
by: O. V. Blagova, et al.
Published: (2015-09-01)

Prognostic impact of angiography-derived index of microcirculatory resistance in patients with dilated cardiomyopathy
by: Takayuki Kawamura, et al.
Published: (2025-09-01)

Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy
by: Anne M. Dybro, et al.
Published: (2025-08-01)

ACUTE GASTRIC DILATATION IN CHILDREN
by: E. Yu. D'yakonovax, et al.
Published: (2014-05-01)

EFFICACY OF CARDIOVERTER-DEFIBRILLATORS IN PREVENTION OF SUDDEN DEATH AND OVERALL MORTALITY DECREASE IN PATIENTS WITH THE SYNDROME OF DILATION CARDIOMYOPATHY: DIFFERENTIAL APPROACH
by: O. V. Blagova, et al.
Published: (2018-03-01)

Sudden cardiac death risk stratification in dilated cardiomyopathy: a state of the art review
by: B. Sh. Berdibekov, et al.
Published: (2025-05-01)

Primary diagnosis of dilated cardiomyopathy in combination with myocardial non-compaction in an elderly patient: a case report
by: Yu. V. Vakhnenko, et al.
Published: (2023-06-01)

HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY
by: V. V. Mazur, et al.
Published: (2016-01-01)

Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers
by: Philip M. Croon, et al.
Published: (2025-07-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment)
by: O. V. Blagova, et al.
Published: (2015-09-01)

MULTISPIRAL COMPUTED TOMOGRAPHY VERSUS MYOCARDIAL BIOPSY IN DIAGNOSTICS OF YOCARDITIS AND PROGNOSIS EVALUATION OF DILATION CARDIOMYOPATHY SYNDROME
by: I. N. Alieva, et al.
Published: (2017-02-01)

Tyrosine phosphatase Shp2 accelerated the progression of dilated cardiomyopathy via upregulating NF-κB/Src/FAK signaling induced ROS and mitophagy
by: Jingxia Hao, et al.
Published: (2025-08-01)

Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy
by: Jan Haas, et al.
Published: (2017-11-01)

Predictors of heart failure in patients with cardiomyopathies of various origins
by: O. O. Kuznetsova, et al.
Published: (2023-11-01)

A BIT* algorithm with dilated vertices-based path stretching strategy
by: Xuanle Wu, et al.
Published: (2025-09-01)